Utility of Select Gene Mutation Detection in Tumors by the Idylla Rapid Multiplex PCR Platform in Comparison to Next-Generation Sequencing

Testing of tumors by next generation sequencing (NGS) is impacted by relatively long turnaround times and a need for highly trained personnel. Recently, Idylla oncology assays were introduced to test for BRAF, EGFR, KRAS, and NRAS common hotspot mutations that do not require specialized trained pers...

Descripción completa

Detalles Bibliográficos
Autores principales: Nkosi, Dingani, Casler, Vektra L., Syposs, Chauncey R., Oltvai, Zoltán N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141835/
https://www.ncbi.nlm.nih.gov/pubmed/35627184
http://dx.doi.org/10.3390/genes13050799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141835/
https://www.ncbi.nlm.nih.gov/pubmed/35627184
http://dx.doi.org/10.3390/genes13050799

Ejemplares similares